about
The Use of an Open Field Model to Assess Sound-Induced Fear and Anxiety Associated Behaviors in Labrador Retrievers.Detection of clinically relevant pain relief in cats with degenerative joint disease associated painClinical trials involving cats: what factors affect owner participation?Relationship between degenerative joint disease, pain, and Bartonella spp. seroreactivity in domesticated cats.Training veterinary students in shelter medicine: a service-learning community-classroom technique.Acquisition of a visual discrimination and reversal learning task by Labrador retrievers.Use of trazodone to facilitate postsurgical confinement in dogs.Criterion Validation Testing of Clinical Metrology Instruments for Measuring Degenerative Joint Disease Associated Mobility Impairment in Cats.The Use of Functional Data Analysis to Evaluate Activity in a Spontaneous Model of Degenerative Joint Disease Associated Pain in Cats.Widespread somatosensory sensitivity in naturally occurring canine model of osteoarthritis.A Feline-Specific Anti-Nerve Growth Factor Antibody Improves Mobility in Cats with Degenerative Joint Disease-Associated Pain: A Pilot Proof of Concept StudyCaregiver placebo effect in analgesic clinical trials for cats with naturally occurring degenerative joint disease-associated pain.Attitudes of small animal practitioners toward participation in veterinary clinical trials.Conditioning laboratory cats to handling and transport.Prevalence and classification of chronic kidney disease in cats randomly selected from four age groups and in cats recruited for degenerative joint disease studies.The use of a T-maze to measure cognitive-motor function in cats (Felis catus)Endogenous Oxytocin, Vasopressin, and Aggression in Domestic Dogs.Olfactory discrimination and generalization of ammonium nitrate and structurally related odorants in Labrador retrievers.Owner-assessed indices of quality of life in cats and the relationship to the presence of degenerative joint disease.A comparison of serum and plasma cytokine values using a multiplexed assay in cats.Evaluation of serum cytokines in cats with and without degenerative joint disease and associated pain.Use of trazodone as an adjunctive agent in the treatment of canine anxiety disorders: 56 cases (1995-2007).Efficacy of a single dose of trazodone hydrochloride given to cats prior to veterinary visits to reduce signs of transport- and examination-related anxiety.Response to Letter to the Editor “LSU–SVM Shelter Medicine Program”Enrichment Preferences of FIV-Infected and Uninfected Laboratory-Housed CatsDevelopment of a checklist for the detection of degenerative joint disease-associated pain in catsDo dog breeds differ in pain sensitivity? Veterinarians and the public believe they doFunctional linear modeling of activity data shows analgesic-mediated improved sleep in dogs with spontaneous osteoarthritis pain
P50
Q30380398-40EB45B5-E474-4863-95A4-1573FD21EC5EQ33783139-3FD41E63-C4EE-41FF-9EE3-79A49BBD9F40Q34802963-E5E4F3E4-1F58-45E2-B82C-5276920DB679Q35531722-2708F542-640E-4B9C-B40B-F3BBCD58B143Q35541613-DD69C932-C33B-4BBD-962C-04E9D4DEF320Q35552125-1A39147C-E1C1-46BE-B6F2-9EE75DCA6F4AQ35552168-8FD43C1D-91DF-4EE7-B85C-5FE07A1AB34BQ35688346-9654F326-ED62-4661-B89A-F8608FCD5A06Q36252584-3EAD1C0C-DE00-4773-979F-0E3AE70176D3Q36900120-7D9FA8ED-0CA4-4DBA-A71C-2E7CB8672F67Q37498237-802CFBB0-568A-40DE-931F-FDA07B62B5EBQ38922286-7C182961-712A-44E1-9944-06D46A283BCDQ39078175-305A60BE-B469-44A4-BC40-8C7CE268D910Q39971187-67B5EC55-11A6-4326-8E35-470B9ED27535Q40069152-98A45B79-EE6C-4479-81D0-235F4C64F459Q41724688-F05484C0-7DA6-4EFA-A1CC-CD1BBCA89957Q42172415-70528165-98F2-45C6-BBE8-35F3D77EC8D6Q44858415-FE3E8085-198D-4F24-978B-9EBF4E31951DQ44866052-D600E2D2-8D59-4BA6-B3A9-991A29713D69Q44868262-DF704A47-24E7-45DD-81AA-C20B311A4915Q44869296-395AFACF-2E18-40BF-91F1-8CECAD2B9E91Q44875735-107ABABE-B042-4DE4-B1DC-007F7D64D005Q47413925-E5CF9B84-A78E-4DC8-80BD-7BE329390215Q57435290-EB608470-E883-4050-9CB1-2C8651FAFCFFQ59357672-F20A5E3C-BF69-4C6B-A47C-D5A8A9C689C5Q89980205-7E1C47E4-91C5-4D34-8EDC-9724752E3ACBQ90390658-0B885BC2-8EFD-421D-9C0F-33713C634AC8Q90441568-12B2F814-BC2E-435C-9D4F-D257C54FB920
P50
description
investigador
@es
researcher
@en
name
Margaret E Gruen
@en
type
label
Margaret E Gruen
@en
prefLabel
Margaret E Gruen
@en
P31
P496
0000-0002-6036-8849